Adam P Dicker Selected Research

Platinum

11/2019	Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer.
1/2018	Beyond Concurrent Chemoradiation: The Emerging Role of PD-1/PD-L1 Inhibitors in Stage III Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam P Dicker Research Topics

Disease

85	Neoplasms (Cancer) 03/2024 - 03/2003
70	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2003
16	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2007
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 07/2012
10	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2005
8	Lung Neoplasms (Lung Cancer) 03/2024 - 10/2013
7	Glioma (Gliomas) 09/2023 - 06/2010
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2013 - 01/2007
6	Disease Progression 12/2018 - 12/2012
5	Adenocarcinoma 11/2016 - 02/2003
4	Carcinoma (Carcinomatosis) 11/2017 - 01/2009
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 01/2007
3	Pain (Aches) 01/2022 - 08/2003
3	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2017
3	Hemorrhage 01/2020 - 02/2003
3	Melanoma (Melanoma, Malignant) 01/2017 - 01/2014
3	Margins of Excision 11/2016 - 12/2014
3	Meningioma (Meningiomas) 09/2012 - 08/2003
2	Fatigue 01/2022 - 10/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 09/2016
2	Breast Neoplasms (Breast Cancer) 11/2018 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2009
2	Cardiotoxicity 01/2018 - 12/2011
2	Extranodal Extension 11/2016 - 12/2014
2	Urinary Incontinence 03/2015 - 08/2004
2	Erectile Dysfunction 03/2015 - 01/2015
2	Retinoblastoma (Glioblastoma, Retinal) 11/2014 - 01/2005
2	Necrosis 04/2014 - 01/2005
2	Hypoxia (Hypoxemia) 01/2014 - 01/2005
2	Colorectal Neoplasms (Colorectal Cancer) 10/2013 - 11/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2009 - 05/2006
1	Astrocytoma (Pilocytic Astrocytoma) 09/2023

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 09/2023 - 06/2004
11	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 06/2004
8	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2018
8	AndrogensIBA 01/2020 - 01/2012
8	ErbB Receptors (EGF Receptor)IBA 11/2017 - 08/2003
7	Hormones (Hormone)IBA 01/2021 - 01/2003
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2004
6	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 06/2009
5	Androgen Receptors (Androgen Receptor)IBA 11/2019 - 02/2012
5	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2007
5	Celecoxib (Celebrex)FDA Link 01/2013 - 08/2003
4	Cetuximab (Erbitux)FDA Link 10/2023 - 05/2012
4	Docetaxel (Taxotere)FDA Link 11/2019 - 03/2003
4	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 01/2013
4	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 01/2007
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014 - 08/2003
3	MicroRNAs (MicroRNA)IBA 10/2023 - 01/2014
3	pembrolizumabIBA 12/2020 - 09/2016
3	IntegrinsIBA 04/2019 - 07/2013
3	Androgen Antagonists (Antiandrogens)IBA 01/2018 - 01/2003
3	Sunitinib (Sutent)FDA Link 10/2014 - 12/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 04/2007
3	Tyrosine Kinase InhibitorsIBA 05/2013 - 01/2012
3	Bortezomib (Velcade)FDA Link 07/2012 - 01/2009
3	Proteasome InhibitorsIBA 07/2012 - 01/2009
2	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2018
2	LigandsIBA 01/2023 - 05/2012
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2014
2	cabazitaxel FDA Link 01/2020 - 02/2015
2	Transaminases (Aminotransferases)IBA 01/2020 - 10/2014
2	PlatinumIBA 11/2019 - 01/2018
2	Radium-223IBA 01/2018 - 08/2017
2	Cytostatic AgentsIBA 01/2018 - 02/2015
2	Panitumumab (Vectibix)FDA Link 01/2017 - 10/2013
2	Monoclonal AntibodiesIBA 09/2016 - 05/2012
2	Taxoids (Taxanes)IBA 02/2015 - 03/2003
2	afliberceptIBA 01/2014 - 04/2007
2	Growth Factor ReceptorsIBA 10/2013 - 01/2012
2	Gefitinib (Iressa)FDA Link 04/2013 - 12/2011
2	Sorafenib (BAY 43-9006)FDA Link 02/2013 - 12/2011
2	epidermal growth factor receptor VIIIIBA 01/2013 - 11/2011
2	Transcription Factors (Transcription Factor)IBA 12/2012 - 01/2009
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2012 - 04/2007
2	cediranib (AZD2171)IBA 01/2012 - 11/2011
2	vandetanib (ZD6474)IBA 01/2012 - 11/2009
2	Angiogenesis InhibitorsIBA 12/2011 - 06/2003
2	NF-kappa B (NF-kB)IBA 01/2009 - 05/2006
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2003 - 08/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2003 - 03/2003
1	ProteomeIBA 03/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024
1	Fluorine-18IBA 03/2024
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2023
1	Radioisotopes (Radionuclides)IBA 01/2023

Therapy/Procedure

88	Radiotherapy 03/2024 - 02/2003
45	Therapeutics 01/2023 - 01/2003
23	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 04/2011
16	Brachytherapy 05/2020 - 07/2002
10	Drug Therapy (Chemotherapy) 03/2024 - 06/2009
9	Chemoradiotherapy 01/2017 - 09/2007
6	Immunotherapy 03/2024 - 09/2016
5	Aftercare (After-Treatment) 01/2020 - 02/2013
5	Castration 11/2019 - 12/2012
4	Re-Irradiation 01/2023 - 06/2010
2	Wearable Electronic Devices 01/2023 - 01/2021
2	Pain Management 01/2022 - 01/2022
2	Conformal Radiotherapy 10/2013 - 10/2008
2	Radiation Dosimeters 03/2013 - 07/2012